C5Q-25480-82974
4 vaccinations
6 coded responses
14 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 704 / LA
- Registered
- 2021-09-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-23
Dose 1 — Pfizer-BioNTech
-
2021-02-13
Dose 2 — Pfizer-BioNTech
-
2021-09-24
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Registered in v-safe
-
2022-04-06
Dose 4 — Pfizer-BioNTech
-
2022-04-07
Survey response — days 1–6 daily, dose 4MedDRA: Joint stiffness, Musculoskeletal stiffness — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: extreme body/joint stiffnessMedDRA releases: 2024-11 · check-in free text available
-
2022-04-08
Survey response — days 1–6 daily, dose 4MedDRA: Joint stiffness, Musculoskeletal stiffness — Feeling: Good · Site: PainFree text: Stiff lower back & right SI/hip areaMedDRA releases: 2024-11 · check-in free text available
-
2022-04-09
Survey response — days 1–6 daily, dose 4MedDRA: Injection site reaction, Muscle fatigue, Myalgia — Feeling: Good · Site: PainFree text: mild tenderness in left deltoid muscle / injection site & slight fatigue when raising that armMedDRA releases: 2024-11 · check-in free text available
- 2022-04-10
-
2022-04-11
Survey response — days 1–6 daily, dose 4MedDRA: Musculoskeletal stiffness — Feeling: GoodFree text: StiffnessMedDRA releases: 2024-11 · check-in free text available
- 2022-04-12
- 2022-04-13
- 2022-04-20
- 2022-04-27
-
2022-05-04
Survey response — day 28, dose 4MedDRA: Autonomic nervous system imbalance, Blood pressure fluctuation, Supraventricular tachycardia, Temperature intolerance — Feeling: FairFree text: Labile blood pressure w/ excessive heat index. Am in middle of BP med-change for SVT/dysautonomia.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-11
- 2022-05-18
-
2022-07-08
Survey response — 3 months, dose 4MedDRA: Cognitive disorder, Exposure to SARS-CoV-2 — Feeling: FairFree text: Two mornings of cognitive slowness (no other signs/ symptoms) abt 4 days after attending a dinner party where one individual later tested +'ve for Covid-19. He's a navy research scientist returned from an assignment to Straits of Gibraltar/Spain.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Pfizer-BioNTech | No |
| 2 | 2021-02-13 | Pfizer-BioNTech | No |
| 3 | 2021-09-24 | Pfizer-BioNTech | No |
| 4 | 2022-04-06 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): extreme body/joint stiffness
Systemic reaction (other): Stiff lower back & right SI/hip area
Systemic reaction (other): mild tenderness in left deltoid muscle / injection site & slight fatigue when raising that arm
Systemic reaction (other): Stiffness
Release 11 — day 28, dose 4
Symptoms: Labile blood pressure w/ excessive heat index. Am in middle of BP med-change for SVT/dysautonomia.
Release 12 — 3 months, dose 4
Symptoms: Two mornings of cognitive slowness (no other signs/ symptoms) abt 4 days after attending a dinner party where one individual later tested +'ve for Covid-19. He's a navy research scientist returned from an assignment to Straits of Gibraltar/Spain.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Autonomic nervous system imbalance | · | · | ✓ |
| SD | Blood pressure fluctuation | · | · | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Supraventricular tachycardia | · | · | ✓ |
| SD | Temperature intolerance | · | · | ✓ |
| SRO | Injection site reaction | · | · | ✓ |
| SRO | Joint stiffness | · | · | ✓ |
| SRO | Muscle fatigue | · | · | ✓ |
| SRO | Musculoskeletal stiffness | · | · | ✓ |
| SRO | Myalgia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release